Very excited to share a challenging case from our centre. A big thank you to our patient for allowing us to publish their case.
https://t.co/07k4AuSHzE
Thank you #anzup25 for the opportunity to present our work on rethinking the role of physical examination in active surveillance programs for men with stage 1 testicular cancer
Very happy to share our recent work!
Review of relapse detection methods in stage 1 testicular germ cell tumours in patients after orchidectomy managed with active surveillance: Is Physical Examination required? - Clinical Genitourinary Cancer https://t.co/G0NOK4durn
Excited to see our paper “An update on metastatic breast cancer – new targeted therapies” now available online. Written to help GPs understand the changing treatment landscape for patients they may see with metastatic breast cancer.
https://t.co/x3fnskJX3j
Congratulations @FXHoneyball on receiving this award for your outstanding contributions to regional oncology and efforts to improve equity of outcomes. Deserved recognition! #oncology
Fantastic research being presented at the MOGA Trainee Orals - none more impressive than @amy_smith90 representing WNSW and SLHD with Impact of Telehealth on Adherence to Surveillence for S1 Testis Ca in Western NSW @MOGA_ORG#MOGA24
J-2156 .... alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking morphine
https://t.co/P9woZarT1W
@MareeSmith19
Angiotensin II type 2 receptor signalling as a pain target: Bench, bedside and back-translation
Andrew J. Shepherd, Andrew SC. Rice, Maree T. Smith
https://t.co/YLQ5h97Ivm @MareeSmith19
Very honoured to be awarded Officer of the Order of Australia today at NSW Government House by her Excellency Governor Margaret Beazley AC KC @Uni_Newcastle @HMRIAustralia
Multitargeted Opioid Ligand Discovery as a Strategy to Retain Analgesia and Reduce Opioid-Related Adverse Effects https://t.co/3J7feMYxYF @MareeSmith19